TRIUMF

Final reminder: The International Workshop on new Photon-Detectors (PD24) will be closing its abstract submission on August 31: https://lnkd.in/gxbFCj6e

We are proud to report that our esteemed Board Chair, Karimah Es Sabar, has been named to the Order of British Columbia. For 35 years this award has been the province’s highest honour, celebrating people who have distinguished themselves and excelled in their field of endeavour, bringing great prestige to the province and beyond. Congratulations Karimah, and the other 11 distinguished recipients! Read more here: https://lnkd.in/g5y6TKxp

Calling all physics fans in Whistler, BC: Join us for a special lecture from TRIUMF's Dr. Cornelia Hoehr, 'How Nuclear Physics Can Treat Cancer', on Sunday, August 18th! Besides being Canada's particle accelerator centre with emphasis on nuclear, particle and accelerator physics, TRIUMF has a long history of medical isotope production and radiotherapy. Cancer treatment with different particles has been a long-standing commitment at TRIUMF, first with pion therapy and then with proton therapy, for many years operating Canada's only proton therapy facility. To improve treatment further, we are researching and establishing FLASH radiotherapy, where the total treatment dose is delivered in less than a second. In addition, we are investigating using alpha and auger emitters for targeted radioisotope therapy. Both have the potential to revolutionize cancer treatment by increasing the therapeutic index. Grab your free ticket for August 18th here: https://lnkd.in/g8W8mWkJ

TRIUMF Science Week 2024 is off to a tremendous start! Today, we kicked off an exciting week with an overview of the laboratory's science program and key highlights, a welcome reception for friends and colleagues, and a special guest lecture from TRIUMF Researcher Emeritus and Royal Society of Canada Fellow, Dr. Tom Ruth, who joined us to explore the role that TRIUMF and Canada have played in the development of the life-saving positron emission tomography (PET) scanning. A special thank-you to our TRIUMF Science Week sponsors, isoSolutions , iseg - High Voltage. Exactly., and Kontron.

#Throwback to the 2024 Canadian Radiotheranostics Leaders’ Summit. Thank you to our event partners, the Canadian Nuclear Isotope Council and University Health Network for helping organize and facilitate many important conversations in our field. We look forward to seeing our sponsors, speakers, and attendees next year as we continue to make advancements!

Get your free tickets to a public lecture on July 22nd at TRIUMF with Tom Ruth: From Vision to Seeing: Tracing the brief history of positron emission tomography in BC and Canada. Abstract: The 1975/76 period saw the perfect convergence of experts in the fields of radiochemistry, basic neuroscience and clinical medical imaging to create the first in vivo (living person) functional images of the human brain using positron emission tomography, PET. This development spurred the US National Institutes of Health to fund 10 US centers to develop human imaging studies in 1980. Recognizing the unique possibilities at TRIUMF and the Neuroscience Programs at UBC, Pat McGeer (an international recognized neuroscientist on leave to serve as a member of the legislature in Victoria) and researchers at TRIUMF (Brain Pate) and Chemistry (Laurie Hall) formed the core to bring this new concept of imaging with PET to British Columbia. Over the next 20+ years the UBC/TRIUMF Program produced some ground breaking findings in the understanding of Parkinsons disease.In the mid 1990s, it became apparent that this technique could be used to help diagnosis cancer and follow the efficacy of treatment. With the help of TRIUMF scientist, the BC Cancer Agency embarked on the development of a clinical program. Integrating the clinical program with a research program through the BC Cancer Research Centre they pursued basic research into the basic mechanism of cancer and to investigate treatments. While other centres in Canada pursued PET, this talk will focus on the TRIUMF contributions of the past, present and a glimpse into the future. Science Week reception open to the public at 5:30 and the lecture will start at 6pm in the auditiorium. Free tickets and more info: https://lnkd.in/ggZK6rqe

Get your free tickets to a public lecture on July 22nd at TRIUMF with Tom Ruth: From Vision to Seeing: Tracing the brief history of positron emission tomography in BC and Canada. Abstract: The 1975/76 period saw the perfect convergence of experts in the fields of radiochemistry, basic neuroscience and clinical medical imaging to create the first in vivo (living person) functional images of the human brain using positron emission tomography, PET. This development spurred the US National Institutes of Health to fund 10 US centers to develop human imaging studies in 1980. Recognizing the unique possibilities at TRIUMF and the Neuroscience Programs at UBC, Pat McGeer (an international recognized neuroscientist on leave to serve as a member of the legislature in Victoria) and researchers at TRIUMF (Brain Pate) and Chemistry (Laurie Hall) formed the core to bring this new concept of imaging with PET to British Columbia. Over the next 20+ years the UBC/TRIUMF Program produced some ground breaking findings in the understanding of Parkinsons disease.In the mid 1990s, it became apparent that this technique could be used to help diagnosis cancer and follow the efficacy of treatment. With the help of TRIUMF scientist, the BC Cancer Agency embarked on the development of a clinical program. Integrating the clinical program with a research program through the BC Cancer Research Centre they pursued basic research into the basic mechanism of cancer and to investigate treatments. While other centres in Canada pursued PET, this talk will focus on the TRIUMF contributions of the past, present and a glimpse into the future. Science Week reception open to the public at 5:30 and the lecture will start at 6pm in the auditiorium. Free tickets and more info: https://lnkd.in/ggZK6rqe

We are thrilled to see a strong investment in the important work of over 100 Canada Research Chairs across physics and other critical areas of Canadian science. These funds support a variety of research, from multi-messenger and astro-particle physics to life sciences, environmental science, and beyond!